table of content
1 Introduction to Research & Analysis Reports
1.1 Vaccines Administered Orally Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccines Administered Orally Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccines Administered Orally Overall Market Size
2.1 Global Vaccines Administered Orally Market Size: 2022 VS 2030
2.2 Global Vaccines Administered Orally Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Vaccines Administered Orally Sales: 2018-2030
3 Company Landscape
3.1 Top Vaccines Administered Orally Players in Global Market
3.2 Top Global Vaccines Administered Orally Companies Ranked by Revenue
3.3 Global Vaccines Administered Orally Revenue by Companies
3.4 Global Vaccines Administered Orally Sales by Companies
3.5 Global Vaccines Administered Orally Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Vaccines Administered Orally Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Vaccines Administered Orally Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccines Administered Orally Players in Global Market
3.8.1 List of Global Tier 1 Vaccines Administered Orally Companies
3.8.2 List of Global Tier 2 and Tier 3 Vaccines Administered Orally Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Vaccines Administered Orally Market Size Markets, 2022 & 2030
4.1.2 Human
4.1.3 Animal
4.2 By Type - Global Vaccines Administered Orally Revenue & Forecasts
4.2.1 By Type - Global Vaccines Administered Orally Revenue, 2018-2023
4.2.2 By Type - Global Vaccines Administered Orally Revenue, 2024-2030
4.2.3 By Type - Global Vaccines Administered Orally Revenue Market Share, 2018-2030
4.3 By Type - Global Vaccines Administered Orally Sales & Forecasts
4.3.1 By Type - Global Vaccines Administered Orally Sales, 2018-2023
4.3.2 By Type - Global Vaccines Administered Orally Sales, 2024-2030
4.3.3 By Type - Global Vaccines Administered Orally Sales Market Share, 2018-2030
4.4 By Type - Global Vaccines Administered Orally Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vaccines Administered Orally Market Size, 2022 & 2030
5.1.2 Public
5.1.3 Private
5.2 By Application - Global Vaccines Administered Orally Revenue & Forecasts
5.2.1 By Application - Global Vaccines Administered Orally Revenue, 2018-2023
5.2.2 By Application - Global Vaccines Administered Orally Revenue, 2024-2030
5.2.3 By Application - Global Vaccines Administered Orally Revenue Market Share, 2018-2030
5.3 By Application - Global Vaccines Administered Orally Sales & Forecasts
5.3.1 By Application - Global Vaccines Administered Orally Sales, 2018-2023
5.3.2 By Application - Global Vaccines Administered Orally Sales, 2024-2030
5.3.3 By Application - Global Vaccines Administered Orally Sales Market Share, 2018-2030
5.4 By Application - Global Vaccines Administered Orally Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Vaccines Administered Orally Market Size, 2022 & 2030
6.2 By Region - Global Vaccines Administered Orally Revenue & Forecasts
6.2.1 By Region - Global Vaccines Administered Orally Revenue, 2018-2023
6.2.2 By Region - Global Vaccines Administered Orally Revenue, 2024-2030
6.2.3 By Region - Global Vaccines Administered Orally Revenue Market Share, 2018-2030
6.3 By Region - Global Vaccines Administered Orally Sales & Forecasts
6.3.1 By Region - Global Vaccines Administered Orally Sales, 2018-2023
6.3.2 By Region - Global Vaccines Administered Orally Sales, 2024-2030
6.3.3 By Region - Global Vaccines Administered Orally Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Vaccines Administered Orally Revenue, 2018-2030
6.4.2 By Country - North America Vaccines Administered Orally Sales, 2018-2030
6.4.3 US Vaccines Administered Orally Market Size, 2018-2030
6.4.4 Canada Vaccines Administered Orally Market Size, 2018-2030
6.4.5 Mexico Vaccines Administered Orally Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Vaccines Administered Orally Revenue, 2018-2030
6.5.2 By Country - Europe Vaccines Administered Orally Sales, 2018-2030
6.5.3 Germany Vaccines Administered Orally Market Size, 2018-2030
6.5.4 France Vaccines Administered Orally Market Size, 2018-2030
6.5.5 U.K. Vaccines Administered Orally Market Size, 2018-2030
6.5.6 Italy Vaccines Administered Orally Market Size, 2018-2030
6.5.7 Russia Vaccines Administered Orally Market Size, 2018-2030
6.5.8 Nordic Countries Vaccines Administered Orally Market Size, 2018-2030
6.5.9 Benelux Vaccines Administered Orally Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Vaccines Administered Orally Revenue, 2018-2030
6.6.2 By Region - Asia Vaccines Administered Orally Sales, 2018-2030
6.6.3 China Vaccines Administered Orally Market Size, 2018-2030
6.6.4 Japan Vaccines Administered Orally Market Size, 2018-2030
6.6.5 South Korea Vaccines Administered Orally Market Size, 2018-2030
6.6.6 Southeast Asia Vaccines Administered Orally Market Size, 2018-2030
6.6.7 India Vaccines Administered Orally Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Vaccines Administered Orally Revenue, 2018-2030
6.7.2 By Country - South America Vaccines Administered Orally Sales, 2018-2030
6.7.3 Brazil Vaccines Administered Orally Market Size, 2018-2030
6.7.4 Argentina Vaccines Administered Orally Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Vaccines Administered Orally Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Vaccines Administered Orally Sales, 2018-2030
6.8.3 Turkey Vaccines Administered Orally Market Size, 2018-2030
6.8.4 Israel Vaccines Administered Orally Market Size, 2018-2030
6.8.5 Saudi Arabia Vaccines Administered Orally Market Size, 2018-2030
6.8.6 UAE Vaccines Administered Orally Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Vaccines Administered Orally Major Product Offerings
7.1.4 Merck Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Vaccines Administered Orally Major Product Offerings
7.2.4 GSK Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Vaccines Administered Orally Major Product Offerings
7.3.4 Sanofi Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Company Summary
7.4.2 Lanzhou Institute Business Overview
7.4.3 Lanzhou Institute Vaccines Administered Orally Major Product Offerings
7.4.4 Lanzhou Institute Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.4.5 Lanzhou Institute Key News & Latest Developments
7.5 Serum Institute
7.5.1 Serum Institute Company Summary
7.5.2 Serum Institute Business Overview
7.5.3 Serum Institute Vaccines Administered Orally Major Product Offerings
7.5.4 Serum Institute Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.5.5 Serum Institute Key News & Latest Developments
7.6 Valneva
7.6.1 Valneva Company Summary
7.6.2 Valneva Business Overview
7.6.3 Valneva Vaccines Administered Orally Major Product Offerings
7.6.4 Valneva Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.6.5 Valneva Key News & Latest Developments
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Company Summary
7.7.2 Shanghai United Cell Business Overview
7.7.3 Shanghai United Cell Vaccines Administered Orally Major Product Offerings
7.7.4 Shanghai United Cell Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.7.5 Shanghai United Cell Key News & Latest Developments
7.8 Bibcol
7.8.1 Bibcol Company Summary
7.8.2 Bibcol Business Overview
7.8.3 Bibcol Vaccines Administered Orally Major Product Offerings
7.8.4 Bibcol Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.8.5 Bibcol Key News & Latest Developments
7.9 PaxVax
7.9.1 PaxVax Company Summary
7.9.2 PaxVax Business Overview
7.9.3 PaxVax Vaccines Administered Orally Major Product Offerings
7.9.4 PaxVax Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.9.5 PaxVax Key News & Latest Developments
7.10 Vabiotech
7.10.1 Vabiotech Company Summary
7.10.2 Vabiotech Business Overview
7.10.3 Vabiotech Vaccines Administered Orally Major Product Offerings
7.10.4 Vabiotech Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.10.5 Vabiotech Key News & Latest Developments
7.11 Tiantan Biological
7.11.1 Tiantan Biological Company Summary
7.11.2 Tiantan Biological Vaccines Administered Orally Business Overview
7.11.3 Tiantan Biological Vaccines Administered Orally Major Product Offerings
7.11.4 Tiantan Biological Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.11.5 Tiantan Biological Key News & Latest Developments
7.12 EuBiologics
7.12.1 EuBiologics Company Summary
7.12.2 EuBiologics Vaccines Administered Orally Business Overview
7.12.3 EuBiologics Vaccines Administered Orally Major Product Offerings
7.12.4 EuBiologics Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.12.5 EuBiologics Key News & Latest Developments
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Company Summary
7.13.2 Panacea Biotec Ltd Vaccines Administered Orally Business Overview
7.13.3 Panacea Biotec Ltd Vaccines Administered Orally Major Product Offerings
7.13.4 Panacea Biotec Ltd Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.13.5 Panacea Biotec Ltd Key News & Latest Developments
7.14 Bio-Med
7.14.1 Bio-Med Company Summary
7.14.2 Bio-Med Business Overview
7.14.3 Bio-Med Vaccines Administered Orally Major Product Offerings
7.14.4 Bio-Med Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.14.5 Bio-Med Key News & Latest Developments
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Company Summary
7.15.2 Halfkin Bio-Pharmaceuticals Business Overview
7.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Major Product Offerings
7.15.4 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.15.5 Halfkin Bio-Pharmaceuticals Key News & Latest Developments
8 Global Vaccines Administered Orally Production Capacity, Analysis
8.1 Global Vaccines Administered Orally Production Capacity, 2018-2030
8.2 Vaccines Administered Orally Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccines Administered Orally Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vaccines Administered Orally Supply Chain Analysis
10.1 Vaccines Administered Orally Industry Value Chain
10.2 Vaccines Administered Orally Upstream Market
10.3 Vaccines Administered Orally Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vaccines Administered Orally Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
